Skip to main content
FinSpry Logo
FinSpry
IMVT logo
IMVT
(NASDAQ)
Immunovant, Inc.
$39.37-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Immunovant, Inc. (IMVT) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Immunovant, Inc. stock.

Analyst Consensus Rating

Investment consensus from 15 professional research analysts

Consensus Rating

Buy
Based on 15 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$45.40
↑ 15.32% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest IMVT Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Sam Slutsky
LifeSci Capital
BuyMaintains
$45.00 → $53.00
Samantha Semenkow
Citi
BuyMaintains
$57.00 → $61.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$66.00
Yatin Suneja
Guggenheim
BuyMaintains
$44.00 → $62.00
Douglas Tsao
HC Wainwright
BuyReiterates
$40.00
Brian Cheng
JP Morgan
BuyMaintains
$35.00 → $47.00
Alex Thompson CFA
Stifel Nicolaus
BuyMaintains
$49.00
Sam Slutsky
LifeSci Capital
BuyInitiates Coverage
$42.00 → $45.00
Danielle Brill
Truist
HoldMaintains
$23.00 → $30.00
Google Biotechnology
TipRanks - Google
HoldUpgrades
$27.00 → $38.00
PerPlexity Biotechnology
TipRanks - PerPlexity
HoldReiterates
$26.00 → $36.00
Anthropic Biotechnology
TipRanks - Anthropic
HoldReiterates
$24.50 → $37.00
xAi Biotechnology
TipRanks - xAI
HoldReiterates
$24.00 → $36.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$25.00 → $38.00
Sam Slutsky
LifeSci Capital
BuyReiterates
$42.00 → $45.00
Danielle Brill
Truist
HoldMaintains
$23.00 → $30.00
Jason Gerberry
BofA Securities
BuyMaintains
$32.00 → $43.00
Derek Archila
Wells Fargo
BuyReiterates
$45.00

Frequently Asked Questions

What is the analyst consensus rating for IMVT?

The analyst consensus rating for IMVT is "Buy" based on 15 analyst recommendations.

What is the average price target for IMVT?

The average 12-month price target for IMVT is $45.40, representing an upside of 15.3% from the current price of $39.37.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.